According to Bangkok Dusit Medical Services (BDMS)'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 30.6143. At the end of 2022 the company had a P/E ratio of 36.7.
Year | P/E ratio | Change |
---|---|---|
2022 | 36.7 | -20.2% |
2021 | 46.0 | -0.48% |
2020 | 46.2 | 76% |
2019 | 26.3 | -37.01% |
2018 | 41.7 | 32.03% |
2017 | 31.6 | -24.82% |
2016 | 42.0 | -2.06% |
2015 | 42.9 | 17.18% |
2014 | 36.6 | 37.65% |
2013 | 26.6 | 19.52% |
2012 | 22.2 | -19.43% |
2011 | 27.6 | 11.63% |
2010 | 24.7 | 41.05% |
2009 | 17.5 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.